Authors


Brian V. Pero

Latest:

Recent Prosecutions on Product Discounts Show Legal Risk Hidden Beneath the Surface

Recent prosecutions have heightened the risk for both market share discounts and discounts in lieu of service fees.


Pharmacy Times Staff

Latest:

Generic Product News: March

Products include oral suspension for gout and tablets that prevent low carnitine levels in the blood.



Nicholas A. Smith, PharmD

Latest:

Augmented Renal Clearance and the Impact on Antimicrobial Therapy

Whether practicing pharmacy in the ambulatory or inpatient setting, professionals devote a substantial amount of energy and time to appropriate dosing of medications for renal impairment.


Jennifer A. Wilson, PharmD, BCACP

Latest:

Melatonin: Considerations for Use in Patients With Sleep Disorders

Melatonin, an endogenous, or natural, hormone mainly produced by the pineal gland in the brain, regulates several body processes, including circadian rhythm and sleep patterns.


Jennifer Barrett

Latest:

Guselkumab Shows Efficacy as Active Psoriatic Arthritis Treatment

Data from 2 studies evaluating guselkumab (Tremfya, Janssen) in active psoriatic arthritis were presented at the American College of Rheumatology and Association of Rheumatology Professionals 2019 Annual Meeting.


Sammy Saab, MD

Latest:

Impact of Drug Therapy Duration in Patients With Hepatitis C

Adherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.



W. Justin Moore, PharmD

Latest:

Cracking the Code of Optimized Influenza Prevention: Cell-Based Influenza Vaccine Advancement

Cell-based vaccines have many potential advantages, one of which includes longer stability and more rapid manufacturing, as cellbased vaccines can be frozen and used at a later date, with dependable cell lines to ensure consistent supply.


Katie Eder, Director of Content

Latest:

Cuvitru Approved for Primary Immunodeficiency

The FDA has just approved Shire's Cuvitru for primary immunodeficiency in patients 2 years and older.


Starlin Haydon-Greatting, MS, BSPharm, FAPhA

Latest:

Relating to the Patient: My Most Influential Experiences

A pharmacist offers her observations on patient-centered care.


Eric Roath, PharmD

Latest:

Lyme Vaccine Moves to Clinical Trials

The FDA recently approved an Investigational New Drug application submitted by Valneva SE.


Mike Hennessy, Sr, Chairman & Founder MJH Life SciencesTM

Latest:

When Will a Vaccine Be Ready?

As we head into flu season, count on Pharmacy Times® to continue to report on the latest developments on COVID-19.


Jeannette Y. Wick, RPh, MBA, FASCPnn

Latest:

Vaccination: What Do Consumers Want to Know?

Researchers from Australia set out to determine health consumers' information needs and concerns related to childhood vaccination.


Michael Carter, Corporate Director of Specialty Pharmacy, President

Latest:

Takeaways from NASP: The State of Pricing Reform Efforts and AI Decision Support in Specialty Pharmacy

The National Association of Specialty Pharmacy's annual meeting is one of the industry’s only conferences where all stakeholders can fully participate.


Daniela Barisano, PharmD Candidate

Latest:

Long Acting Reversible Contraceptives and Chlamydia: No Increased Risk

A team of researchers from Columbia University, New York City compared the incidence of chlamydia infection in adolescent LARC users to non-LARC users.


Amer Zeidan, MD

Latest:

Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies

Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.



Thomas Cohn, Chief Strategy Officer, Asembia

Latest:

Reimagining Specialty Pharmacy: Market Variability Drives New Strategies

A common theme during this year’s summit was the uncertainty about the profitability of the existing specialty pharmaceutical model.


James M. Lightwood, PhD

Latest:

Effect of Dispensing Supply on Pravastatin Refill Adherence

In uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.



Tina Valbh, BS Pharm, RPh, Axium Healthcare Pharmacy

Latest:

The Value Potential of Biosimilars in the United States

Pharmacists must understand the potential value of biosimilars as a competitive generation of more cost efficient drugs hit the market.


Jasmin Tawfic, PharmD candidate

Latest:

Leukemia: Causes, Symptoms, and Treatments

Leukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.


Rolee Pathak Das, PharmD, BCPS

Latest:

Making Sense of Allergic Rhinitis: A Pharmacist's Primer on General Overview and Treatment of Allergic Rhinitis

Pharmacists can learn about current management of allergic rhinitis, including allergen avoidance, immunotherapy, and pharmacotherapy.





Albert Bach, PharmD, APh

Latest:

Point-of-Care Testing Offers New Opportunities

Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.


Fei Yu, MS

Latest:

Unique Considerations for Specialized Patient Populations for Pharmacies Utilizing Appointment-Based Care Models: Part 2

While there is a reasonable body of research on many of the diverse causes of medication nonadherence, there are much fewer data on the effectiveness of various interventions.


Nick Culbertson

Latest:

The Addiction Crisis in America’s Hospitals: Clinical Drug Diversion

Health care compliance analytics can be used to roll out institution-wide training and education programs to deter sloppy or nefarious behavior related to controlled substances.